BY Christopher Karlsson

Leo Pharma’s proprietors stay positive regarding a prospective IPO in 2026, in spite of the business not anticipating to reach its target of a minimal 20% incomes margin this…

The brand-new chair has actually belonged to Biogen’s board of supervisors given that 2021.

Via the brand-new system, Gubra intends to purchase medicine tasks getting in the professional stage, with the purpose of introducing a brand-new firm in 2026, according to the bra…

With its European growth, the Bioinnovation Institute (BII) is likewise preparing to establish brand-new funds for international financial investments.

In 2026, GN anticipates its listening devices tasks to add natural development of in between 3 and 7%.

Eli Lilly’s GLP-1 medicines created DKK 231bn in sales in 2014, DKK 3bn greater than Novo Nordisk’s leading medication in the exact same classification.

Mike Doustdar, Chief Executive Officer of Novo Nordisk, claims the pharmaceutical business’s assumptions for 2026 stand for the business’s most practical analysis of ad…

/PRNewswire/ — Unitree Robotics, a world chief most frequently-purpose robotics trend, issued an decent clarification referring to its 2025 sales and shipment figures on January 22, 2026, in response to misinformation circulating on-line. The firm’s fats observation is as follows: Clarification Regarding Unitree’s 2025 Sales Knowledge 1. Over the previous month, many objects of

Semaglutide is currently authorized to deal with MASH in the United States, however in the EU the therapy seems called Kayshild.